Valeant Pharmaceuticals International Executive Pay Doubles to $19.7 Million Despite Quadrupling of Company’s Losses

BNET -- Valeant Pharmaceuticals saw its revenues decline, its net loss quadruple, and its cash sink by $109 million in 2008. But the compensation of its top executives doubled, to $19.7 million in 2008 from $8.6 million in 2007.